How much does Test n Share make per month?

Our model estimates Test n Share earns roughly $93/mo, but with only 14 ratings the confidence interval is wide. No founder-verified MRR is available for this app, so this is a model output calibrated against comparable apps in the same category. See methodology for the formula.

What apps are like Test n Share?

Browse the full Medical category catalog to find similar apps with revenue, build cost, audience and tech stack data. Each /p/{slug} page also shows a Compare side-by-side widget with three peer apps from the same niche.

What is Test n Share built with?

Our heuristic places Test n Share on the Native Android (Kotlin) stack (High confidence, 80%). Signals: app bundle size, category context, store-description markers, release-date era. We don't disassemble binaries. Alternative possibilities: Flutter.

Is Test n Share still actively maintained?

Maintenance status: Slowing (25% abandonment risk). Last shipped version was 2 months ago. The risk score combines time-since-last-update with Editor's Choice / curated featuring + user-base maturity adjustments.

When was Test n Share last updated?

Test n Share last shipped a new version on 2026-07-22 — 2 months ago. This is the date Apple / Google last accepted a new build, not a content-only push.

Who makes Test n Share?

Test n Share is published by Test n Share on the Google Play Store. See the full publisher portfolio (other apps by the same developer) via the More by developer block on the product page above.

What is Test n Share's BU Score?

Test n Share has a BU Score of 37/100 (Emerging). The score combines App Store rating, ratings count, monetization model and revenue signals calibrated against founder-verified MRR anchors. See the BU Score formula.

Test n Share

Quality Score

Emerging

Test n Share

Name: Test n Share — app revenue, audience, build cost & risk profile
Creator: Bumetric
License: https://creativecommons.org/licenses/by/4.0/
Keywords: Test n Share revenue, Test n Share app analytics, mobile app revenue estimate, Medical revenue, Android app revenue

by Test n Share

Low confidence

3.1 Google Play rating

✍️ Bumetric analysis

“

Test n Share is an Android app from Test n Share in the Medical category, currently rated 3.1★ across 14 ratings. Initial signal reads as largely positive sentiment, users highlighting consistency and feature depth.

Quality Score is 37: Emerging (early traction worth watching). For a Medical app, that means early traction worth watching. The full BU Investment Matrix below scores 8 dimensions including monetisation, growth, and operational risk.

Track changes month-over-month in the Performance section below: live snapshot history and revenue forecast included.

💰 Monthly revenue · now vs forecast

● Right now

$93

per month

→

12-mo forecast

$47 – $433

per month

→

24-mo forecast

$47 – $1298

per month

MICRO tier

💡 Grow this revenue

Free AI audit of this app’s store listing

Title & subtitle keyword fit
Description hook & conversion structure
Screenshots, ratings, reviews strategy

Run free AI audit →

Typical impact: +2-5× organic installs

📊 Performance Tracking LIVE

1 snapshots on record

idle

Rating

3.1

Reviews

14 reviews

Forecast Revenue / mo

$93

Snapshots tracked

since Aug 2026

ONE-TIME · BUILD 💰 Estimated build cost

$175K

↳ What it cost to build · not monthly revenue

Likely range $130K – $235K

$25K · MVP floor $100K · indie scale $500K+ · studio build

📈 Slow ROI — current MRR is well below build cost

Synthetic estimate. Inputs: category complexity, file size, screen count, monetization layer, platform reach, age × team-size proxy. Calibrated against 2024-2026 indie-agency rate surveys. Full math + source list on /methodology.

Where the money goes

🧱 MVP baseline (design + 1-store ship)	+$28K
📱 5 unique screens × $4.5K	+$22K
⚙ Medical complexity ×1.55	+$27K
🌐 Cross-platform reach (iOS + Android)	+$43K
⚙ 9.2y maintenance × ~1-person team	+$55K

Total estimate $175K

🛠 Estimated tech stack

🤖

Native Android (Kotlin)

High confidence · 80%

Also possible

Flutter

Heuristic guess from app bundle size, category, store description signals, and release-date stack era. Bumetric does not disassemble binaries — for binary-level certainty you would need an SDK intelligence tool or the manifest itself. Reasoning chain on the right. Full ruleset on /methodology.

Signals we read

🏷 Category context	Medical
📦 Compact Android bundle	→ Native Kotlin

💀 Maintenance status

Slowing

25%

Last shipped 2026-07-22 · 66 days ago

0 · Active 50 · At risk 100 · Abandoned

Heuristic risk score from time-since-last-update + ratings velocity proxy + Editor's Choice / curated featuring signals. Calibrated against 2024-2025 app-store ranking decay reports. Not a guarantee — a quiet app with a healthy codebase looks the same as an abandoned one until something breaks. Full math on /methodology.

Risk signals

📅 66 days since last update	Healthy release cadence
👥 Small user base (14 ratings) + 9.2y old	+10% (solo-project pattern)

Verdict Slowing

🔬

How we forecast this revenue

LOW CONFIDENCE

Baseline

$93/mo · ML-estimated from 234 triggers

Growth rate

+8.0% MoM · MICRO tier baseline (compound monthly)

Direction

Headwinds: rating drift may slow acquisition

6 months

$59 – $236

12 months

$47 – $433

24 months

$47 – $1.3K

Compound growth at +8.0% MoM (tier baseline for MICRO). Range widens with horizon — typical noise band ±60% at 6mo.. Ranges widen with horizon — distant futures carry more uncertainty.

📊

BU Investment Matrix

Insufficient data · 32/100MICRO TIERtoo early to score

Revenue Strength

2.0

Product Quality

2.5

Market Position

0.0

Growth Velocity

5.0

Defensibility

4.3

Operational Safety

8.0

Founder Strength

3.0

Monetization Maturity

1.0

💰 Revenue: Marginal — $0 - $500/mo · MICRO tier · indicative confidence, trajectory unclear.
⭐ Quality: 3.15★ across 14 reviews — weak — significant quality concerns.
📍 Market: Not yet charting in any of the 9 monitored markets.
📈 Growth: Insufficient signal to assess trajectory.
⚠️ Risk: Moderate — no material risk signals detected.

🎯 For competitors: Mixed picture. Worth competing if you have a clear UX or pricing edge — otherwise crowded segment.

💵 For acquirers: Estimated asking range 18-32× monthly = $1K-$2K.

Composite of 8 dimensions computed deterministically from public signals — no LLM, every score traces back to a measurable input. Default weights shown; "compete" / "acquire" / "invest" lenses re-weight without re-fetching.

Range:

💰 Forecast Revenue / mo

MODEL

Revenue forecast computed from BU's 234 trigger model on each snapshot. Calibrated against ground-truth from 58 verified-revenue apps.

🔬Forecast Breakdown — Why This Estimate?Top 4 of 4 triggers

Our ML model uses 200+ signals from public data. These are the most influential for this app:

Below-average rating (3.1★)METRIC		−$1,500
Mature app (9y old)METRIC		+$1,500
Ad-supported / freemiumMETRIC		+$600
Pre-traction phase (14 ratings)METRIC		−$300

METRIC = structural app data · REVIEW = mined from user reviews · ✓ VERIFIED = Stripe-verified anchor (TrustMRR)

📥 Estimated Downloads / week

PROXY · ratings × 50/wk —

Industry-rule estimate (Sensor Tower / data.ai): one weekly install ≈ 50 new ratings. Solid points = tracked snapshots · faded line = pre-tracking model backfill.

📈 Reviews Growth

LIVE

Cumulative review count from first BU snapshot. Each point = a tracked update.

⭐ Rating Trend

LIVE

Average rating evolution. Updates with each new review batch.

🗓️ Snapshot Timeline

HISTORY

Each bar shows a tracked update and the metric delta from the previous snapshot.

Profile & Insights

Everything we know — and don't — about this app and its company.

Identification

App name: Test n Share
Developer: Test n Share
Bundle ID: com.testnshare.health
App Store URL: Open in App Store
Category: Medical
Content rating: Not found
Languages: Not found

Company

Website: www.testnshare.com
Tagline: Not found
Description: Not found
Founded: Not found
HQ / Address: Not found
Employees: Not found
Logo: Not found

Revenue

Reported revenue signal / mo: Not found
AI revenue estimate / mo: Not found
AI annual estimate: Not found
Model estimate / mo: $93/mo
Top-grossing rank: Not found
All-time revenue: Not found
Pricing: Not found

Founder

Founder data not yet collected for this app.

Funding

Funding data not yet collected for this app.

Press & Links

Press & Links data not yet collected for this app.

Contacts & Socials

Contacts & Socials data not yet collected for this app.

Profile is built from iTunes Lookup + developer site scrape + ML revenue model. Empty fields show "Not found" — additional sources (Crunchbase, X, IndieHackers, Acquire.com) coming.

📝 About this app

Test n Share offers a simple way to transmit health measurements from:

•	Glucose Monitor

•	Blood Pressure Monitor

•	Weight Scale

•	Ear Thermometer

•	Finger Pulse Oximeter

To a HIPAA compliant health cloud which allows members of the patient’s healthcare team, family and friends to receive unrestricted, unlimited access to historical diagnostic test results, as well as elect to receive event notifications based on your care team digital care plan prescribed for you.… View full description on the official store →

App Specs

🔐 Own this app? Claim & verify MRR →

🔖 v6.2.2🔄 updated 2mo ago📂 Medical💰 Free🚀 Launched 2017 (9y old)

🧪